Abstract
Get full access to this article
View all access options for this article.
References
1.
Denborough
MH
Forster
JFA
Lovell
RRH
Maplestone
PA
Villiers
JD
. Anaesthetic Deaths in a Family . Br J Anaesth
1962 ; 34 : 395 –6
2.
Neubauer
KR
Kaufman
RD
. Another use for mass spectrometry. Detection and monitoring of malignant hyperthermia . Anesth Analg
1985 ; 64 : 837
3.
Brownell
AK
. Malignant hyperthermia: relationship to other diseases . Br J Anaesth
1988 ; 60 : 303 –8
4.
Muldoon
SM
. Muscle disease, malignant hyperthermia, and myasthenia . Curr Opinion Anaesth
1993 ; 6 : 578 –81
5.
McGuire
N
Easy
WR
. Malignant hyperthermia during isoflurane anaesthesia . Anaesthesia
1990 ; 45 : 124 –7
6.
Sims
C
. Masseter spasm after suxamethonium in children . Br J Hosp Med
1992 ; 47 : 139 –43
7.
Ward
A
Chaffman
MO
Sorkin
EM
. Dantrolene: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity . Drugs
1986 ; 32 : 130 –68
8.
Halsall
PJ
Cain
PA
Ellis
FR
. Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperthermia was recognised . Br J Anaesth
1979 ; 51 : 949 –54
9.
Rutberg
H
Hakanson
E
. Malignant hyperthermia: Clinical course and metabolic changes in two patients . Acta Anaesthesial Scand
1986 ; 30 : 211 –14